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Take-home message: Evidence
underpinning national guidance to replace
central venous catheters after admission to
intensive care predates major quality
improvement initiatives and improved
infection control in UK paediatric intensive
care units. We used national linked data to
demonstrate that inter-hospital transfer is no
longer a significant risk factor for
bloodstream infection and suggest that
strategies to further reduce bloodstream
infection should focus on maintaining
sterile procedures after admission.
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Abstract Purpose: Adherence to
full sterile procedures may be com-
promised when central venous
catheters are inserted as part of
emergency resuscitation and stabili-
sation, particularly outside the
intensive care unit. Half of emer-
gency admissions to paediatric
intensive care units (PICU) in the UK
occur after stabilisation at other hos-
pitals. We determined whether
bloodstream infection (BSI) occurred
more frequently in children admitted
to PICU after inter-hospital transfer
compared to within-hospital admis-
sions. Methods: Data on emergency
admissions to 20 PICUs in England
and Wales for children \16 years
between 2003–2012 were linked from
the national PICU audit database
(PICANet) and national infection
surveillance (LabBase2). PICU-
acquired BSI was defined as any
positive blood culture sampled
between 2 days after admission and
2 days following discharge from
PICU. Results: A total of 32,861/
62,515 (53 %) admissions were inter-
hospital transfers. Multivariable
regression showed no significant dif-
ference in rates of PICU-acquired BSI
by source of admission (incidence-
rate ratio for inter-hospital transfer
versus within-hospital admis-
sion = 0.97; 95 % CI 0.87–1.07)
after adjusting for other risk-factors.
Rates decreased more rapidly
between 2003 and 2012 for inter-
hospital transfers: 17.0 % (95 % CI
14.9–19.0 % per year) compared with
12.4 % (95 % CI 9.9–14.9 % per
year) for within-hospital admissions.
The median time to first PICU-
acquired BSI did not differ signifi-
cantly between inter-hospital
transfers (7 days; IQR 4–13) and
within-hospital admissions (8 days;
IQR 4–15). Conclusions: Nation-
ally, inter-hospital transfer is no
longer a significant risk factor for
PICU-acquired BSI. Given the large
proportion of infection occurring in
the second week of admission, ini-
tiatives to further reduce PICU-
acquired BSI should focus on main-
taining sterile procedures after
admission.
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Introduction
Bloodstream infections (BSI) are an important cause of
mortality, prolonged stay and excess healthcare costs in
paediatric intensive care units (PICU) [1–3]. An estimated
70 % of BSIs occurring in PICU are thought to be related
to the use of central venous catheters (CVCs) [4]. Over
the past decade, implementation of care bundles to
improve the sterility of CVC insertion have resulted in
significant reductions in the rate of catheter-related BSI in
adult and paediatric ICUs worldwide [5–9].
Risk factors for BSI in critically ill children with a
CVC relate to patient susceptibility (e.g. immunodefi-
ciency, need for blood transfusion and renal replacement
therapy) and the catheter (sterility of insertion, type of
catheter material, number of CVCs and duration of
catheterisation) [10–12]. The potential for full aseptic
technique during CVC insertion is likely to be compro-
mised during emergency stabilisation. This has resulted in
national guidelines recommending elective replacement
of the CVC after admission to intensive care [13–17].
Evidence from single-centre studies showing an increased
risk of BSI in patients whose CVC was inserted outside
the ICU underpins these guidelines, but partly predates
major improvements in infection control across the UK
National Health Service, including specific bundles of
care to improve sterile procedures during CVC insertion
[13].
We use national linked data to determine how trends
in BSI differed in children admitted after inter-hospital
transfer compared with within-hospital admission to
PICU. Our study covers a period of 10 years, during
which time national quality improvement initiatives
related to CVC care were implemented (Saving Lives in
2007 and Matching Michigan in 2009) [18, 19]. Falling
rates of BSI over recent years have not been restricted to
children with CVCs but have been observed in all chil-
dren in PICU (who may be subjected to a number of
invasive procedures). We therefore chose to include all
children admitted to PICU in this study.
Materials and methods
Study population
The study population comprised all admissions between
March 2003 and December 2012 of children aged
\16 years to the 22 PICUs in England and Wales with at
least 200 admissions per year. Data were extracted from
the Paediatric Intensive Care Audit Network (PICANet),
which records source of admission and clinical informa-
tion but does not capture information on BSI or CVC
insertion [20]. All PICUs in England and Wales have
contributed data to PICANet since March 2003.
We linked records of PICU admissions to records of
BSI recorded in the national infection surveillance system
in England and Wales (LabBase2). This is a voluntary
system coordinated by Public Health England (PHE) [21].
Hospital laboratories are requested to report all clinically
significant isolates from blood, but there is variation in
how clinical significance is defined and hence in judging
which isolates should be reported. We have previously
reported 80–95 % ascertainment of BSI by Labbase2 and
shown that incomplete reporting is not related to patient
or organism characteristics [22]. The linked dataset
comprised admissions to 20/22 PICUs in England and
Wales (two PICUs did not report sufficient data to Lab-
Base2 during the study period).
A detailed description of the linkage between PICA-
Net and LabBase2 has been reported elsewhere [22].
Briefly, a combination linkage methods were used to
identify PICANet admission records that had a corre-
sponding record of BSI in LabBase2, based on agreement
between NHS number, hospital number, first name, sur-
name, date of birth, postcode, sex and location (laboratory
and hospital) [23].
Case definition
We defined an episode of BSI as any positive blood
culture with one or more organisms isolated from any
blood sample taken on the same day. Since PICANet does
not routinely capture the presence of a CVC during PICU
admission, we were unable to determine whether BSI
recorded in LabBase2 were related to CVCs or not. Our
analysis therefore studied all BSI, and includes any CVC-
related or CVC-associated BSI as well as BSI from ven-
tilator-associated pneumonia or catheter-associated
urinary tract infection. As a sensitivity analysis, we
restricted analyses to children receiving vasoactive agents
and requiring invasive ventilation, as these children
would be very likely to also require a CVC.
We defined PICU-acquired BSI as any BSI occurring
from samples taken from 2 days after admission to 2 days
after discharge from PICU. This definition excluded
samples taken on the day of admission or the day after
admission to PICU, as positive samples on these days
may be more reflective of events leading up to admission.
We included samples taken on the 2 days following dis-
charge from PICU and so children staying\2 days could
have a PICU-acquired BSI if a sample was taken in the
2 days following discharge. This definition may mean
that a small proportion of PICU-acquired occurring in the
first 2 days of admission are missed (\5 %) [24].
As a secondary analysis, we also evaluated early BSI
in PICU (occurring between days 0–7 of admission). This
analysis aimed to capture any BSI occurring in the first
week of admission (i.e. BSI occurring in the first 2 days
of PICU admission and those occurring between days 2–7
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of PICU admission). We hypothesised that any effect on
BSI of CVC insertion during emergency stabilisation at
another hospital could be most apparent within the first
week of PICU admission, based on data showing the risk
of BSI from insertion of non-cuffed CVCs to be highest in
the first few days [25].
Repeated samples with positive cultures of the same
organism within 14 days were treated as the same epi-
sode. This meant that, for children who already had BSI
on admission, we only included PICU-acquired BSI in
analysis if the organism from samples taken after
admission was a different organism. As laboratory records
included the date but not the time the specimen was taken,
some included samples may have been taken between 24
and 48 h after admission to PICU.
Comparisons of PICU-acquired BSI were restricted to
emergency admissions (unplanned admissions as defined
within PICANet), since children admitted electively
would likely have had a CVC inserted under sterile con-
ditions in the operating theatre. Children with unknown
source or type of admission were excluded (Fig. 1).
Statistical analysis
Univariable associations between clinical characteristics
and PICU-acquired BSI were assessed using Chi-squared
tests (categorical variables) or Mann–Whitney tests
(continuous variables). Analysis was performed using
Stata 12 [26].
The primary analysis determined whether trends
(change over time) in BSI per 1,000 bed-days differed
between children with an emergency admission to PICU
after inter-hospital transfer compared to within-hospital
admission. These analyses used Poisson regression,
adjusting for potential confounders including primary
diagnosis at admission, ventilation status and Paediatric
Index of Mortality (PIM2) score (see Table 1) [27]. Dif-
ferences in trends in PICU-acquired BSI by source of
admission (inter-hospital transfer versus within-hospital
admission) were assessed through the inclusion of an
interaction term for trend and source of admission.
Time to PICU-acquired BSI was defined as the num-
ber of days between admission and the date of the first
PICU-acquired BSI. The difference in time to PICU-
acquired BSI between inter-hospital and within-hospital
transfers was assessed using multivariable Cox regres-
sion. Random effects for PICUs were included in models
to account for clustering of admissions within PICUs.
We also separately analysed PICU-acquired BSI due
to skin and non-skin organisms, as we hypothesised that
infection control practices might have had more impact
on BSI due to skin organisms acquired during CVC
insertion. Skin organisms were defined as coagulase
negative staphylococcus, Staphylococcus epidermidis,
Corynebacterium spp. or Proprionibacterium spp. All
other organisms were classified as non-skin organisms. As
BSI could be due to skin organisms, non-skin organisms
or both, numbers of BSI due to skin and non-skin
organisms exceed the total number of BSI.
Results
Bloodstream infections in PICU
Figure 1 shows the number of records included in the
analysis. Admission characteristics are shown in Table 1.
For the 62,515 emergency admissions between March
2003 and December 2012, there were 1628 episodes of
PICU-acquired BSI, and 1353 admissions (2.2 %) expe-
rienced at least one PICU-acquired BSI. This equated to
an overall rate of 4.97 (95 % CI 4.73–5.22) PICU-
acquired BSI per 1,000 bed-days.
141 164 
admissions 2003-2012
102 999 admissions 
(excluding LabBase2 
reporng gaps)
39 899 (39%) elecve 
admissions
62 868 (61%) emergency 
admissions
62 515 (99%) complete 
data for source of 
admission
32 861 (53%) inter-
hospital transfers
29 654 (47%) within-
hospital admissions
300 (<0.5%) admied 
from home or outpaent 
clinic
53 (<0.1%) missing data 
232 (<0.5%) admission 
type not known 
Fig. 1 Study profile. Dashed box records included in analysis
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The percentage of admissions acquiring BSI following
inter-hospital transfer (56 %) was greater than for within-
hospital admissions (42 %). However, after adjusting for
significant risk factors (calendar period of admission
measured by quarter-year, age, renal support, diagnosis
group, and ventilation status, see Table 1 in Supplement)
there was no significant difference in rates of PICU-
acquired BSI by source of admission. The incidence-rate
ratio for inter-hospital transfer versus within-hospital
admission was 0.97 (95 % CI 0.87–1.07). There was,
however, a significant interaction between source of
admission and time, with rates decreasing more rapidly
for inter-hospital transfers (17.0 %; 95 % CI 14.9–19.0 %
per year) compared with 12.4 % (95 % CI 9.9–14.9 % per
year) for within-hospital admissions (p = 0.026).
The sensitivity analysis included 14,393 children who
required invasive ventilation and who received vasoactive
agents. For these admissions, there were 937 episodes of
PICU-acquired BSI, and 763 admissions (5.3 %) experi-
enced at least one PICU-acquired BSI (7.03 per 1,000
bed-days; 95 % CI 6.09–7.97). The incidence-rate ratio
for inter-hospital transfer versus within-hospital
Table 1 Characteristics of
emergency admissions to UK
PICUs for children aged
\16 years, 2003–2012
(univariable analysis)
Admissions with no PICU-
acquired BSI (n = 61,162)
Admissions with PICU-
acquired BSI (n = 1,353)
p value
Admission source
Inter-hospital transfer 32,082 (52 %) 779 (58 %) \0.0001
Within-hospital admission 29,080 (48 %) 574 (42 %)
Sex
Male 35,349 (58 %) 762 (56 %) 0.174
Female 25,767 (42 %) 591 (44 %)
Unknown 46 (0 %) 0 (0 %)
Age
\1 year 28,472 (47 %) 773 (57 %) \0.0001
1–4 years 16,407 (27 %) 334 (25 %)
5–10 years 8,520 (14 %) 139 (10 %)
11–15 years 7,763 (13 %) 107 (8 %)
Vasoactive agents 14,768 (24 %) 774 (57 %) \0.0001
Renal support 1,910 (3 %) 210 (15 %) \0.0001
Admitted after surgery 5,415 (9 %) 86 (6 %) 0.001
PIM2
\1 % 12,499 (20 %) 110 (8 %) \0.0001
1–5 % 26,393 (43 %) 425 (31 %)
5–15 % 15,785 (26 %) 496 (37 %)
15–30 % 3,626 (6 %) 194 (14 %)
30 %? 2,860 (5 %) 127 (9 %)
Primary diagnosis
Cardiovascular 8,264 (14 %) 299 (22 %) \0.0001
Respiratory 22,847 (37 %) 373 (28 %)
Infection 4,899 (8 %) 254 (19 %)
Other 25,152 (41 %) 427 (32 %)
Ventilation status
Neither 17,463 (29 %) 163 (12 %) \0.0001
Non-invasive only 3,740 (6 %) 23 (2 %)
Invasive only 31,860 (52 %) 752 (56 %)
Both 7,298 (12 %) 387 (29 %)
Unknown 800 (1 %) 29 (2 %)
PICU size (average admissions per year)
0–650 23,059 (38 %) 355 (26 %) \0.0001
650–1000 24,718 (40 %) 628 (46 %)
[1000 13,385 (22 %) 370 (27 %)
PICU type
General 27,656 (45 %) 476 (35 %) \0.0001
Mixed 32,837 (54 %) 850 (63 %)
Cardiac 669 (1 %) 27 (2 %)
Area admitted from
A&E 16,907 (28 %) 227 (17 %) \0.0001
HDU 3,850 (6 %) 94 (7 %)
ICU / PICU / NICU 8,075 (13 %) 272 (20 %)
Other intermediate care 1,188 (2 %) 38 (3 %)
Recovery only 264 (0 %) 5 (0 %)
Theatre and recovery 7,025 (11 %) 118 (9 %)
Ward 20,818 (34 %) 539 (40 %)
X-ray/endoscopy/CT 474 (1 %) 4 (0 %)
Unknown 2,560 (4 %) 57 (4 %)
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admission was similar to that in the main analysis: 0.98
(95 % CI 0.86–1.13). In this group, who were likely to
have required CVCs, rates also decreased more rapidly
for inter-hospital transfers (17.5; 95 % CI 17.0–18.0)
compared with 12.6 (95 % CI 10.4–14.5) for within-
hospital admissions (p = \0.001).
In the secondary analysis restricting the outcome to
early BSI (occurring between days 0–7 of admission),
there was no significant difference in rates by source of
admission (incidence-rate ratio for inter-hospital transfer
vs. within-hospital admission = 0.97; 95 % CI
0.89–1.05). Trends were similar in both groups (p value
for interaction term = 0.66).
Overall, non-skin organisms dominated as causative
organisms for PICU-acquired BSI (3.76; 95 % CI
3.61–3.91 per 1,000 bed-days for non-skin organisms vs.
1.61; 95 % CI 1.51–1.71 for skin organisms). This was
consistent for both inter-hospital transfers and within-
hospital admissions. Trends seen in PICU-acquired BSI
due to skin organisms and due to non-skin organisms
reflected those seen overall (Fig. 2). There was no sig-
nificant difference in rates or trends of either type of
organism between inter-hospital transfers or within-hos-
pital admissions.
Time to PICU-acquired BSI
The percentage of admissions acquiring BSI in PICU
increased with length of stay (Table 2). The median
time to PICU-acquired BSI did not differ between inter-
hospital transfers (7 days from admission; IQR 4–13)
and within-hospital admissions (8 days; IQR 4–15).
Between 2003 and 2012, there was no significant dif-
ference by admission source in time to PICU-acquired
BSI (hazard ratio for inter-hospital transfers versus
within-hospital admissions = 0.93; 95 % CI 0.83–1.04,
Fig. 3) or for early BSI (hazard ratio = 0.96; 95 % CI
0.87–1.06).
The median time to PICU-acquired BSI due to skin
organisms was 8 (IQR 4–16) and 7 (IQR 4–13) days for
non-skin organisms. There was no significant difference
in time to PICU-acquired BSI either due to skin
organisms (hazard ratio for inter-hospital transfer vs.
within-hospital admissions = 0.90; 95 % CI 0.73–1.13)
or non-skin organisms (hazard ratio = 0.91; 95 % CI
0.79–1.04).
Discussion
Our study shows that, in England and Wales, the risk of
BSI acquired in PICU did not vary according to whether a
child had an emergency admission to PICU following
inter-hospital transfer from another hospital or were
within-hospital admissions. Previously described risk
factors for BSI, such as need for renal support and longer
PICU stay, were associated with a greater risk of BSI in
our study [10, 12, 28, 29]. Rates of PICU-acquired BSI
have continued to fall over the past decade, at a greater
rate in inter-hospital transfers than in within-hospital
admissions, coincident with several national quality
improvement initiatives [18, 19]. Our findings are
Fig. 2 Trends in PICU-
acquired bloodstream infection
(log-scale) due to skin
organisms or non-skin
organisms by admission source
and quarter-year of admission.
Symbols observed rates, lines
adjusted smoothed rates
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important in guiding national policy on where future
efforts to reduce BSI in PICU should be targeted.
Our study is the first to analyse BSI data at a national
level in emergency admissions to PICUs in England and
Wales. The main strength of our study was the national
coverage of our linked dataset and the long study period
of 10 years. We were also able to analyse microbiological
data on a large proportion of all PICU admissions during
the study period ([70 %). We chose to study all BSI,
rather than just BSI related to the presence of a CVC,
since children on a PICU are subjected to many invasive
procedures, all of which may increase the risk of BSI.
The main weakness of our study, which limits our
ability to directly compare our results with previous sin-
gle-centre studies, was that the linked national dataset did
not contain information on which patients had a CVC
during their stay in PICU (or where it was inserted and the
circumstances surrounding its insertion). As such, any
true differences in CVC insertion practice between inter-
hospital transfers and within-hospital admissions con-
tributing to the development of PICU BSI could have
been masked, biasing our results towards the null. How-
ever, since approximately 40–60 % of emergency
admissions to PICU require a CVC (unpublished audit
data), and since rates of BSI in children without CVCs are
low, differences in trends in BSI seen in our study seen
between inter-hospital and within-hospital admissions are
likely to be related to the use of CVCs. Furthermore, our
sensitivity analysis evaluating rates in children requiring
vasoactive agents and invasive ventilation showed results
almost identical to those in all children, although absolute
BSI rates were higher in this group.
There are several potential explanations for our find-
ings. First, the fact that BSI rates decreased more rapidly
in the inter-hospital transfer group over the years may be
related to differences between the groups studied despite
adjustment for case mix and severity of illness, with
respect to the type of CVC used (CVCs in inter-hospital
transfers were more likely to be short-term non-tunnelled
catheters, whereas within-hospital admissions were more
likely to have long-term tunnelled catheters), patient
susceptibility (within-hospital admissions more likely to
have impaired host defence), presence of co-morbidities
(more frequent in within-hospital admissions) and length
of CVC use. Second, inter-hospital transfers may have
benefited more from the implementation of national
quality improvement initiatives. Third, the fact that there
was no difference in the time to BSI within the first week
between the groups may be explained by the use of
antibiotics, which may have delayed the onset of inser-
tion-related BSI beyond the first week of admission in
inter-hospital transfers.
Our study demonstrates that routine replacement of
CVCs inserted in trauma and other emergencies is not
justified in critically ill children, as, in England and Wales,
children with CVCs inserted following stabilisation are
not at a higher risk of BSI. Further, since the rate of BSI
has reduced significantly over the past decade, future
attempts to eliminate BSI may need to focus more on
practice related to the maintenance of CVCs. Studies from
other settings have emphasised the importance of CVC
maintenance-related care bundles in the reduction of BSI
in PICUs, particularly due to the frequent use of tunnelled
long-term CVCs in this population [30, 31]. Further
research focusing on the influence of co-morbidities, CVC
Table 2 Percentage of admissions with PICU-acquired BSI by length of stay
Patient length
of stay
n admissions Admissions with
PICU-acquired BSIa
Admissions with
PICU-acquired BSI
due to skin organismsa
Admissions with
PICU-acquired BSI
due to non-skin organismsa
Admissions
with early
BSIb
\2 days 27,031 86 (0.3 %) 45 (0.2 %) 110 (0.4 %) 733 (2.7 %)
2 to \7 days 23,337 337 (1.4 %) 149 (0.6 %) 367 (1.6 %) 1,110 (4.8 %)
7 to \14 days 7,712 314 (4.1 %) 127 (1.7 %) 316 (4.1 %) 433 (5.6 %)
14 to \21 days 2,185 206 (9.4 %) 101 (4.6 %) 178 (8.1 %) 133 (6.1 %)
21 to \28 days 881 110 (12.5 %) 49 (5.6 %) 109 (12.4 %) 54 (6.1 %)
28? days 1,369 300 (21.9 %) 172 (12.5 %) 322 (23.5 %) 65 (4.7 %)
a PICU-acquired BSI occurring between 2 days after admission and up to 2 days after discharge
b Early BSI occurring in days 0–7 of admission
Fig. 3 Survival curve for cumulative incidence of PICU-acquired
BSI by admission source
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type and exposure, and differential use of antibiotics, on
BSI rates in national PICU cohorts is required.
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